Synthesized Polymers-Functionalized PEG
Synthesized Polymers-Functionalized PEG
Seebio Biotech, Inc. provides a variety of Synthesized Polymers such as Functionalized Polystyrene (PS), Functionalized Polyisoprene (PI), Functionalized Polyvinylpyridine ,block Copolymer(33) and so on.
Please contact us for more natural or synthesized polymers.
Product Detail:
1. Functionalized PEG (262)
No.
Description
Structure
1
mPEO-OH
2
mPEO-COOH
3
mPEO-COOH
4
mPEO-COOH
5
mPEO-SC
6
mPEO-SCM
7
mPEO-SPA
8
mPEO-SS
9
mPEO-ALD
10
mPEO-ALD
11
mPEO-ALD
12
mPEO-NH2
13
mPEO-NH2
14
mPEO-MAL
15
mPEO-MAL
16
mPEO-SH
17
mPEO- Propargyl
18
mPEO-Allyl
19
mPEO- Acryloyl
20
mPEO-Br
21
mPEO-TEMPO
22
mPEO-OTS
23
mPEO-N3
Parameters:
Molecular Weight Range, 500-500,000Da
PDI, ≤1.08
Package: 1mg-5000g
1.1 Monofunctional PEG(23)
1.2 Bifunctional PEG (23)
|
No. |
Description |
Structure |
|
1 |
HO-PEG-OH |
|
|
2 |
HOOC-PEG-COOH |
|
|
3 |
HOOC-PEG-COOH |
|
|
4 |
HOOC-PEG-COOH |
|
|
5 |
SC-PEG-SC |
|
|
6 |
SCM-PEG-SCM |
|
|
7 |
SPA-PEG-SPA |
|
|
8 |
SS-PEG-SS |
|
|
9 |
ALD-PEG-ALD |
|
|
10 |
ALD-PEG-ALD |
|
|
11 |
ALD-PEG-ALD |
|
|
12 |
NH2-PEG-NH2 |
|
|
13 |
NH2-PEG-NH2 |
|
|
14 |
MAL-PEG-MAL |
|
|
15 |
MAL-PEG-MAL |
|
|
16 |
HS-PEG-SH |
|
|
17 |
Propargyl-PEG-Propargyl |
|
|
18 |
Allyl -PEG-Allyl |
|
|
19 |
Acryloyl-PEG-Acryloyl |
|
|
20 |
Br-PEG-Br |
|
|
21 |
TEMPO-PEG-TEMPO |
|
|
22 |
OTS-PEG-OTS |
|
|
23 |
N3-PEG- N3 |
|
1.3 Heterofunctional PEG (69)
|
No. |
Description |
Structure |
|
1 |
HO-PEG-COOH |
|
|
2 |
HO-PEG- COOH |
|
|
3 |
HO-PEG- ALD |
|
|
4 |
HO-PEG- ALD |
|
|
5 |
HO-PEG- ALD |
|
|
6 |
HO-PEG- NH2 |
|
|
7 |
HO-PEG- MAL |
|
|
8 |
HO-PEG- SH |
|
|
9 |
HO-PEG- Propargyl |
|
|
10 |
HO-PEG- Allyl |
|
|
11 |
HO-PEG- TEMPO |
|
|
12 |
ALD-PEG- COOH |
|
|
13 |
ALD-PEG- COOH |
|
|
14 |
ALD-PEG- SH |
|
|
15 |
ALD-PEG- Propargyl |
|
|
16 |
ALD-PEG- Allyl |
|
|
17 |
ALD-PEG- TEMPO |
|
|
18 |
ALD-PEG- COOH |
|
|
19 |
ALD-PEG- COOH |
|
|
20 |
ALD-PEG- SH |
|
|
21 |
ALD-PEG- Propargyl |
|
|
22 |
ALD-PEG- Allyl |
|
|
23 |
ALD-PEG- TEMPO |
|
|
24 |
ALD-PEG- COOH |
|
|
25 |
ALD-PEG- COOH |
|
|
26 |
ALD-PEG-SH |
|
|
27 |
ALD-PEG- Propargyl |
|
|
28 |
ALD-PEG- Allyl |
|
|
29 |
ALD-PEG-TEMPO |
|
|
30 |
TEMPO-PEG-OH |
|
|
31 |
TEMPO-PEG-COOH |
|
|
32 |
TEMPO-PEG-COOH |
|
|
33 |
TEMPO-PEG-COOH |
|
|
34 |
TEMPO-PEG-SC |
|
|
35 |
TEMPO-PEG-SCM |
|
|
36 |
TEMPO-PEG-SPA |
|
|
37 |
TEMPO-PEG-SS |
|
|
38 |
TEMPO-PEG-ALD |
|
|
39 |
TEMPO-PEG-ALD |
|
|
40 |
TEMPO-PEG-ALD |
|
|
41 |
TEMPO-PEG-SH |
|
|
42 |
TEMPO-PEG-Propargyl |
|
|
43 |
TEMPO-PEG-Allyl |
|
|
44 |
TEMPO-PEG- Acryloyl |
|
|
45 |
TEMPO-PEG- Br |
|
|
46 |
TEMPO-PEG- OTs |
|
|
47 |
TEMPO-PEG- N3 |
|
|
48 |
Allyl-PEG-COOH |
|
|
49 |
Allyl-PEG-COOH |
|
|
50 |
Allyl-PEG-COOH |
|
|
51 |
Allyl-PEG-SC |
|
|
52 |
Allyl-PEG-SCM |
|
|
53 |
Allyl-PEG-SPA |
|
|
54 |
Allyl-PEG-SS |
|
|
55 |
Allyl-PEG-ALD |
|
|
56 |
Allyl-PEG-ALD |
|
|
57 |
Allyl-PEG-ALD |
|
|
58 |
Allyl-PEG- SH |
|
|
59 |
Allyl-PEG-Propargyl |
|
|
60 |
Allyl-PEG- Acryloyl |
|
|
61 |
Allyl-PEG-Br |
|
|
62 |
Allyl-PEG-OTs |
|
|
63 |
Allyl-PEG-N3 |
|
|
64 |
HOOC-PEG-OH |
|
|
65 |
HOOC-PEG-OH |
|
|
66 |
NH2-PEG-OH |
|
|
67 |
NH2-PEG-COOH |
|
|
68 |
NH2-PEG-OH |
|
|
69 |
NH2-PEG-COOH |
|
1.4 2-Armed V-shaped PEG (45)
|
No. |
Description |
Structure |
|
1 |
(HOOC-PEO)2-OH |
|
|
2 |
(HOOC-PEO)2-OH |
|
|
3 |
(ALD-PEO)2-OH |
|
|
4 |
(ALD-PEO)2-OH |
|
|
5 |
(ALD-PEO)2-OH |
|
|
6 |
(Propargyl-PEO)2-OH |
|
|
7 |
(Allyl-PEO)2-OH |
|
|
8 |
(TEMPO-PEO)2-OH |
|
|
9 |
(mPEO)2-OH |
|
|
10 |
(mPEO)2-COOH |
|
|
11 |
(mPEO)2-COOH |
|
|
12 |
(mPEO)2-COOH |
|
|
13 |
(mPEO)2-SC |
|
|
14 |
(mPEO)2-SCM |
|
|
15 |
(mPEO)2-SPA |
|
|
16 |
(mPEO)2-SS |
|
|
17 |
(mPEO)2-ALD |
|
|
18 |
(mPEO)2- ALD |
|
|
19 |
(mPEO)2- ALD |
|
|
20 |
(mPEO)2-NH2 |
|
|
21 |
(mPEO)2- NH2 |
|
|
22 |
(mPEO)2-MAL |
|
|
23 |
(mPEO) 2-MAL |
|
|
24 |
(mPEO)2-SH |
|
|
25 |
(mPEO)2-Propargyl |
|
|
26 |
(mPEO)2-Allyl |
|
|
27 |
(mPEO)2- Acryloyl |
|
|
28 |
(mPEO)2-Br |
|
|
29 |
(mPEO)2-TEMOPO |
|
|
30 |
(mPEO)2-Ts |
|
|
31 |
(mPEO)2-N3 |
|
|
32 |
(HOOC-PEO)2-Allyl |
|
|
33 |
(HOOC-PEO)2-Allyl |
|
|
34 |
(Propargyl-PEO)2-Allyl |
|
|
35 |
(HO-PEO)2-COOH |
|
|
36 |
(HO-PEO)2-COOH |
|
|
37 |
(HO-PEO)2-NH2 |
|
|
38 |
(HOOC-PEO)2- NH2 |
|
|
39 |
(HOOC-PEO)2- NH2 |
|
|
40 |
(HOOC-PEO)2-OH |
|
|
41 |
(HOOC-PEO)2-OH |
|
|
42 |
(mPEO)2-COOH |
|
|
43 |
(mPEO)2-COOH |
|
|
44 |
(mPEO)2-NH2 |
|
|
45 |
(mPEO)2-OH |
|
1.5 3-Armed Y-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)2-(PEO-OH) |
|
|
2 |
(mPEO)2-(PEO-COOH) |
|
|
3 |
(mPEO) 2-(PEO-SC) |
|
|
4 |
(mPEO) 2-(PEO-SPA) |
|
|
5 |
(mPEO) 2-(PEO-MAL) |
|
|
6 |
(mPEO)2-(PEO-ALD) |
|
|
7 |
(mPEO)2-(PEO-NH2) |
|
|
8 |
(mPEO) 2-(PEO-SH) |
|
|
9 |
(mPEO) 2-(PEO-Propargyl) |
|
|
10 |
(mPEO)2-(PEO-Allyl) |
|
|
11 |
(mPEO)2- (PEO-Acryloyl) |
|
|
12 |
(mPEO) 2- (PEO-Br) |
|
|
13 |
(mPEO)2- (PEO-TEMPO) |
|
|
14 |
(mPEO)2- (PEO-Ts) |
|
|
15 |
(mPEO) 2- (PEO-N3) |
|
1.6 3-Armed V-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)3-OH 3-(PEO-OH) |
|
|
2 |
(mPEO)3-COOH 3-(PEO-COOH) |
|
|
3 |
(mPEO)3-SC3-(PEO-SC) |
|
|
4 |
(mPEO)3-SPA(mPEO)3-(PEO-SPA) |
|
|
5 |
(mPEO)3-MAL3-(PEO-MAL) |
|
|
6 |
(mPEO)3-ALD 3-(PEO-ALD) |
|
|
7 |
(mPEO)3-NH23-(PEO-NH2) |
|
|
8 |
(mPEO)3-SH3-(PEO-SH) |
|
|
9 |
(mPEO)3-Propargyl3-(PEO-Propargyl) |
|
|
10 |
(mPEO)3-Allyl3-(PEO-Allyl) |
|
|
11 |
(mPEO)3-Acryloyl- (PEO-Acryloyl) 3 |
|
|
12 |
(mPEO)3-Br3- (PEO-Br) |
|
|
13 |
(mPEO)3-TEMPO3- (PEO-TEMPO) |
|
|
14 |
(mPEO)3-Ts 3- (PEO-Ts)(mPEO)3-N3 |
|
|
15 |
(mPEO)3- (PEO-N 3) |
|
1.7 4-Armed Y-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)3-(PEO-OH)2-(PEO-OH) |
|
|
2 |
(mPEO)3-(PEO-COOH)2-(PEO-COOH) |
|
|
3 |
(mPEO)3-(PEO-SC) 2-(PEO-SC) |
|
|
4 |
(mPEO)3-(PEO-SPA) 2-(PEO-SPA) |
|
|
5 |
(mPEO)3-(PEO-MAL)(mPEO)2-(PEO-MAL) |
|
|
6 |
(mPEO)3-(PEO-ALD)2-(PEO-ALD) |
|
|
7 |
(mPEO)3-(PEO-NH2) 2-(PEO-NH2) |
|
|
8 |
(mPEO)3-(PEO-SH)2-(PEO-SH) |
|
|
9 |
(mPEO)3-(PEO-2-(PEO-Propargyl Propargyl)) |
|
|
10 |
(mPEO)3-(PEO-Allyl) 2-(PEO-Allyl) |
|
|
11 |
(mPEO)3-(PEO-Acryloyl)2- (PEO-Acryloyl) |
|
|
12 |
(mPEO)3-(PEO-Br) 2- (PEO-Br) |
|
|
13 |
(mPEO)3-(PEO-TEMPO)2- (PEO-TEMPO) |
|
|
14 |
(mPEO)3-(PEO-Ts)(mPEO) 2- (PEO-Ts) |
|
|
15 |
(mPEO)3-(PEO-N3) 2- (PEO-N3) |
|
1.8 Dendrimer-like PEG (30)
|
No. |
Description |
Structure |
|
1 |
(mPEO) 4-(PEO)2-OH |
|
|
2 |
(mPEO) 4-(PEO)2-COOH |
|
|
3 |
(mPEO) 4-(PEO)2-SC |
|
|
4 |
(mPEO) 4-(PEO)2-SPA |
|
|
5 |
(mPEO) 4-(PEO)2-MAL |
|
|
6 |
(mPEO) 4-(PEO)2-ALD |
|
|
7 |
(mPEO) 4-(PEO)2-NH2 |
|
|
8 |
(mPEO) 4-(PEO)2-SH |
|
|
9 |
((mPEO) 4-(PEO)2-Propargyl |
|
|
10 |
(mPEO) 4-(PEO)2-Allyl |
|
|
11 |
(mPEO) 4-(PEO)2-Acryloyl |
|
|
12 |
(mPEO) 4-(PEO)2-Br |
|
|
13 |
(mPEO) 4-(PEO)2-TEMPO |
|
|
14 |
(mPEO) 4-(PEO)2-Ts |
|
|
15 |
(mPEO) 4-(PEO)2-N3 |
|
|
16 |
(mPEO) 4-(PEO)2-PEO-OH |
|
|
17 |
(mPEO) 4-(PEO)2-PEO-COOH |
|
|
18 |
(mPEO) 4-(PEO)2- PEO-SC |
|
|
19 |
(mPEO) 4-(PEO)2- PEO-SPA |
|
|
20 |
(mPEO) 4-(PEO)2-PEO-MAL |
|
|
21 |
(mPEO) 4-(PEO)2-PEO-ALD |
|
|
22 |
(mPEO) 4-(PEO)2- PEO-NH2 |
|
|
23 |
(mPEO) 4-(PEO)2- PEO-SH |
|
|
24 |
((mPEO)4-(PEO)2-PEO-Propargyl |
|
|
25 |
(mPEO) 4-(PEO)2-PEO-Allyl |
|
|
26 |
(mPEO) 4-(PEO)2-PEO-Acryloyl |
|
|
27 |
(mPEO) 4-(PEO)2- PEO-Br |
|
|
28 |
(mPEO) 4-(PEO)2-PEO-TEMPO |
|
|
29 |
(mPEO) 4-(PEO)2- PEO-Ts |
|
|
30 |
(mPEO) 4-(PEO)2- PEO-N3 |
|
1.9 3-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
3Arm (PEO-OH) 3 |
|
|
2 |
3Arm (PEO-COOH)3 |
|
|
3 |
3Arm (PEO-SH)3 |
|
|
4 |
3Arm (PEO-NH2)3 |
|
|
5 |
3Arm (PEO-Propargyl) 3 |
|
|
6 |
3Arm (PEO- Allyl3 |
|
|
7 |
3Arm (PEO- Acryloyl )3 |
|
|
8 |
3Arm (PEO-Br )3 |
|
|
9 |
3Arm (PEO- N 3)3 |
|
1.10 4-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
4Arm (PEO-OH)4 |
|
|
2 |
4Arm (PEO-COOH)4 |
|
|
3 |
4Arm (PEO-NH2)4 |
|
|
4 |
4Arm (PEO-SH)4 |
|
|
5 |
4Arm (PEO-Propargyl)4 |
|
|
6 |
4Arm (PEO- Allyl)4 |
|
|
7 |
4Arm (PEO- Acryloyl )4 |
|
|
8 |
4Arm (PEO-Br )4 |
|
|
9 |
4Arm (PEO- N3)4 |
|
1.11 6-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
6Arm (PEO-OH) 6 |
|
|
2 |
6Arm (PEO-COOH) 6 |
|
|
3 |
6Arm (PEO-SH) 6 |
|
|
4 |
6Arm (PEO- NH 2)6 |
|
|
5 |
6Arm (PEO-Propargyl) 6 |
|
|
6 |
6Arm (PEO- Acryloyl )6 |
|
|
7 |
6Arm (PEO- Allyl ) 6 |
|
|
8 |
6Arm (PEO- Br)6 |
|
|
9 |
6Arm (PEO-N 3)6 |
|
1. A variety of functional groups, good performance, high-purity,Mw 500-80,000, Polydispersity Index(PDI)less than 1.05;
2. The production process is simplified, low impurity n ice stability;
3. More than 400 various types, nearly 2,000 kinds of product;
4. Customized products and service.
1. Functionalized PEG (262)
1.1 Monofunctional PEG(23)
1.2 Bifunctional PEG (23)
1.3 Heterofunctional PEG (69)
1.4 2-Armed V-shaped PEG (45)
1.5 3-Armed Y-shaped PEG (15)
1.6 3-Armed V-shaped PEG (15)
1.7 4-Armed Y-shaped PEG (15)
1.8 Dendrimer-like PEG (30)
1.9 3-Armed PEG (9)
1.10 4-Armed PEG (9)
1.11 6-Armed PEG (9)
2. Funcationlaized Subsititued Poly(ether) (12)
3. Functionalized Polystyrene (PS) (36)
4. Functionalized Polyisoprene (PI)(20)
5. Functionalized Polyvinylpyridine (PVP) (36)
Please contact us for more natural or synthesized polymers.
Seebio Biotech, Inc.
11-502. Lane 299, Bisheng Rd.
Zhangjiang High Tech Park
Shanghai 201204, P.R.China
Tel: 86-21-50272975, 76, 77, 78, 79, 81,Ext:6513,6515,6516,6520,6521,6522
For customers' complaint or suggestion： 86-21-50272981-6821, 6818
Web： www.seebio.cn
Email：fyland@seebio.cn service@seebio.cn
MSN：seebio8@hotmail.com
Skype：seebiocn
 |
 |
 |
| 官网：www.cxbio.com | 微信服务号：iseebio | 微博：seebiobiotech |
 |
 |
 |
| 商城：mall.seebio.cn | 微信订阅号：seebiotech | 泉养堂：www.canmedo.com |
相关资讯
- Cell Rep：科学家揭示肠道菌群影响代谢疾病的新线索
- Science Immunology研究证实：鼻腔喷雾剂对阻止变异至关重要
- Science子刊：新型纵向研究记录了在症状出现5个月后的COVID-19抗体反应
- 早期肾损伤诊断用NAG底物
- 攻克阿尔茨海默症的曙光！纳米酶复合材料或可改善阿尔茨海默症
- 琼脂糖-镍磁珠--纯化和筛选组氨酸标记的蛋白
- 快速了解这种甲级传染病及其预防措施
- 2020年分子诊断市场有望达到93亿美元
- Ludger高通量甲基化检测方法
- 《Science》子刊：首次发现失眠是致命性脑动脉瘤破裂的潜在危险因素
新进产品
同类文章排行
- 胆碱酯酶检测原料一览
- 猴痘病毒检测原料（涵盖诊断酶、抗原、抗体），西宝生物助力猴痘检测
- 西宝生物CHO细胞、HEK293细胞、 Vero细胞培养基产品
- 人和动物免疫球蛋白IgG全新上市
- 如何选择合适的表面活性剂？
- 尿液分析试纸检测原理及产品推荐
- 总胆红素/直接胆红素检测一站式解决方案
- 分子诊断用酶原料一站式服务尽在西宝生物
- 体外诊断中交联剂的用途与选择
- 优异的化妆品级水溶性β-1,3-葡聚糖
资讯文章
您的浏览历史
